Amanda Cano
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 13
- Advanced Drug Delivery Systems 12
- Physiology 18
- Alzheimer's disease research and treatments 16
- Co-authors
- Eliana B. Souto (39 shared papers)Elena Sánchez‐López (43 shared papers)Miren Ettcheto (42 shared papers)Antoni Camins (41 shared papers)María L. García (28 shared papers)Marta Espina (22 shared papers)Amélia M. Silva (7 shared papers)Ana López-Machado (7 shared papers)
In The Last Decade
Amanda Cano
68 papers receiving 4.0k citations
Amanda Cano's Hit Papers
Peers
Comparison fields: 5 of 152
- Pharmaceutical Science 854
- Biomaterials 718
- Biological Psychiatry 80
- Molecular Medicine 162
- Complementary and alternative medicine 194
Countries citing papers authored by Amanda Cano
This map shows the geographic impact of Amanda Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Cano more than expected).
Fields of papers citing papers by Amanda Cano
This network shows the impact of papers produced by Amanda Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Cano. The network helps show where Amanda Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metal-Based Nanoparticles as Antimicrobial Agents: An Overview Hit paper breakdown → | 2020 | 1068 |
| 2 | 2019 | 258 | |
| 3 | 2018 | 202 | |
| 4 | Microemulsions and Nanoemulsions in Skin Drug Delivery Hit paper breakdown → | 2022 | 200 |
| 5 | 2019 | 187 | |
| 6 | 2022 | 148 | |
| 7 | 2019 | 143 | |
| 8 | 2016 | 122 | |
| 9 | 2021 | 100 | |
| 10 | 2020 | 87 | |
| 11 | 2021 | 82 | |
| 12 | 2021 | 74 | |
| 13 | 2018 | 70 | |
| 14 | 2019 | 66 | |
| 15 | 2020 | 62 | |
| 16 | 2020 | 62 | |
| 17 | 2021 | 59 | |
| 18 | 2019 | 58 | |
| 19 | 2021 | 56 | |
| 20 | 2021 | 51 |
About Amanda Cano
Amanda Cano is a scholar working on Pharmaceutical Science, Physiology, Molecular Biology, Pharmacology and Biomaterials, having authored 70 papers that have together received 4.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (16 papers), Advancements in Transdermal Drug Delivery (13 papers), Advanced Drug Delivery Systems (12 papers), Nanoparticle-Based Drug Delivery (9 papers), Cholinesterase and Neurodegenerative Diseases (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Tryptophan and brain disorders (5 papers) and Tea Polyphenols and Effects (5 papers). The work is most often cited by research in Pharmaceutical Science (854 citations), Biomaterials (718 citations), Biological Psychiatry (80 citations), Molecular Medicine (162 citations) and Complementary and alternative medicine (194 citations). Amanda Cano has collaborated with scholars based in Spain, Portugal and Brazil. Frequent co-authors include Eliana B. Souto, Elena Sánchez‐López, Miren Ettcheto, Antoni Camins, María L. García, Marta Espina, Amélia M. Silva, Ana López-Machado, Ruth Galindo and Gerard Esteruelas. Their work appears in journals such as Pharmaceutics, International Journal of Molecular Sciences, Biomedicine & Pharmacotherapy, Nanomaterials and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.